KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Vir Biotechnology (VIR) Leases (2020 - 2025)

Vir Biotechnology's Leases history spans 6 years, with the latest figure at $62.1 million for Q4 2025.

  • For Q4 2025, Leases rose 4.05% year-over-year to $62.1 million; the TTM value through Dec 2025 reached $62.1 million, up 4.05%, while the annual FY2025 figure was $62.1 million, 4.05% up from the prior year.
  • Leases for Q4 2025 was $62.1 million at Vir Biotechnology, down from $63.6 million in the prior quarter.
  • Across five years, Leases topped out at $88.3 million in Q1 2022 and bottomed at $57.6 million in Q3 2021.
  • The 5-year median for Leases is $67.6 million (2024), against an average of $70.5 million.
  • The largest annual shift saw Leases surged 289.96% in 2021 before it fell 16.91% in 2024.
  • A 5-year view of Leases shows it stood at $87.2 million in 2021, then fell by 5.35% to $82.6 million in 2022, then fell by 13.78% to $71.2 million in 2023, then decreased by 16.16% to $59.7 million in 2024, then increased by 4.05% to $62.1 million in 2025.
  • Per Business Quant, the three most recent readings for VIR's Leases are $62.1 million (Q4 2025), $63.6 million (Q3 2025), and $64.9 million (Q2 2025).